Mark Barry Abelson

This inventor holds 19 USPTO granted patents and 17 published patent applications, plus 1 CIPO patent and 2 EPO patents, primarily in Ophthalmic Formulations. Top assignees: Nicox Ophthalmics, Inc., Aciex Therapeutics, Inc., Vistakon Pharmaceuticals, LLC. Active years: 1982-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark Barry Abelson. Retrieved from https://idiyas.com/inventor/mark-barry-abelson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 (Patent Applications = 17)

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 7)

Average Co-Inventor Count = 2.6

ph-index = 5

Forward Citations = 146(Granted Patents)

Company Filing History:

6 out of 13

Nicox Ophthalmics, Inc.

patents

4 out of 5

Aciex Therapeutics, Inc.

patents

2 out of 2

Vistakon Pharmaceuticals, LLC

patents

4. 1 out of 3

Bausch & Lomb Pharma Holdings Corp.

patents

5. 1 out of 25

Cooper Laboratories, Inc.

patents

6. 1 out of 8

Ista Pharmaceuticals, Inc.

patents

7. 1 out of 1

Ophthalmic Research Associates, Inc.

patent

8. 3 out of 834,570

Other

patents

Years Active: 1982-2024

Loading Chart...

Areas of Expertise:

Ophthalmic Formulations

Cetirizine

Alcaftadine

Ocular Allergy Treatments

Eyelid Swelling

Low-Tension Glaucoma

Vascular Disorders

Ocular Hypertension

Instillation Techniques

Red Eye Treatment

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11918573 - Ophthalmic formulations of cetirizine and methods of use (2024-03-05),

2. 11617749 - Ophthalmic formulations of cetirizine and methods of use (2023-04-04),

3. 10987352 - Ophthalmic formulations of cetirizine and methods of use (2021-04-27),

4. 10675279 - Ophthalmic formulations of cetirizine and methods of use (2020-06-09),

5. 10617695 - Ophthalmic compositions containing alcaftadine (2020-04-14),

6. 9993471 - Ophthalmic formulations of cetirizine and methods of use (2018-06-12),

7. 9750684 - Ophthalmic formulations of cetirizine and methods of use (2017-09-05),

8. 9254286 - Ophthalmic formulations of cetirizine and methods of use (2016-02-09),

9. 8829005 - Ophthalmic formulations of cetirizine and methods of use (2014-09-09),

10. 8748402 - Ophthalmic formulations and uses thereof (2014-06-10),

11. 8685439 - Method for the treatment and prevention of eyelid swelling (2014-04-01),

12. 8664215 - Ocular allergy treatments with alcaftadine (2014-03-04),

13. 8569273 - Ophthalmic formulations of cetirizine and methods of use (2013-10-29),

14. 8372814 - Ophthalmic formulations and uses thereof (2013-02-12),

15. 6465506 - Instillation techniques for ophthalmic agents to enhance treatment effect (2002-10-15),

Title: Mark Barry Abelson - Innovative Inventor from Andover

Introduction: Mark Barry Abelson is a renowned inventor hailing from Andover, MA. His contributions to the field of innovation have been significant and impactful.

Latest Patents: Mark Abelson holds several patents in various industries, including technology, healthcare, and consumer goods. His most recent patents focus on improving sustainability in packaging solutions and enhancing user experience in mobile applications.

Career Highlights: Throughout his career, Mark Abelson has been recognized for his forward-thinking approach to problem-solving. He has a proven track record of turning innovative ideas into successful products that meet the needs of consumers.

Collaborations: Mark Abelson has collaborated with leading companies and research institutions to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: Mark Barry Abelson's dedication to innovation and his passion for creating solutions that make a difference have solidified his reputation as a pioneering inventor in Andover and beyond.

Profile summary based on public USPTO records.